Preoperative Neutrophil-to-Lymphocyte Ratio Predicts the Prognosis of Oral Squamous Cell Carcinoma: A Large-Sample Prospective Study

J Oral Maxillofac Surg. 2017 Jun;75(6):1275-1282. doi: 10.1016/j.joms.2016.11.022. Epub 2016 Dec 5.

Abstract

Purpose: To assess and determine the prognostic value of the preoperative neutrophil-to-lymphocyte ratio (NLR) in patients with oral squamous cell carcinoma (OSCC).

Materials and methods: The prospective study involving 1,202 patients with OSCC and surgical resection was carried out in Fujian, China. Two-stage analyses were performed by randomly dividing all patients into 800 discovery and 402 replication sets. The optimal NLR cutoff points were identified by the X-tile program with minimum P values. Prognostic factors were evaluated using univariate and multivariate Cox regression models.

Results: The discovery set was categorized as low-, middle-, and high-risk groups based on optimal NLR cutoff points (<1.94, 1.94 to 3.66, and >3.66, respectively). A high NLR was meaningfully associated with an increased risk of death on survival (NLR 1.94 to 3.66, hazard ratio [HR] = 1.51; 95% confidence interval [CI], 1.09-2.08; NLR >3.66, HR = 1.76; 95% CI, 1.21-2.55). In the replication phase, patients with a high NLR showed considerably worse overall survival compared with those with a low NLR (NLR 1.94 to 3.66, HR = 1.61; 95% CI, 1.02-2.55; NLR >3.66, HR = 1.94; 95% CI, 1.16-3.27). In addition, better overall survival was observed for patients with a higher NLR who had received postoperative chemoradiotherapy (HR = 0.49; 95% CI, 0.26-0.92).

Conclusion: The preoperative NLR is an independent factor in predicting the prognosis of OSCC, especially for patients with chemoradiotherapy, which could serve as a potential target for improving patients' prognosis.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell / blood*
  • Carcinoma, Squamous Cell / pathology*
  • Carcinoma, Squamous Cell / surgery
  • Female
  • Humans
  • Lymphocytes / pathology*
  • Male
  • Middle Aged
  • Mouth Neoplasms / blood*
  • Mouth Neoplasms / pathology*
  • Mouth Neoplasms / surgery
  • Neoplasm Staging
  • Neutrophils / pathology*
  • Prognosis
  • Prospective Studies
  • Random Allocation
  • Survival Rate